Skip to main content
. 2017 Jun 9;11(6):e0005646. doi: 10.1371/journal.pntd.0005646

Table 3. Trait differences between subarachnoid and ventricular neurocysticercosis.

Subarachnoid neurocysticercosis
N = 114
Ventricular neurocysticercosis
N = 63
P
Age at diagnosis 44.2 ± 11.8 36.2 ± 12.0 < 0.0001
Sex (male) 62 (54.4) 29 (46.0) 0.29
Symptoms
Headache 34 (29.8) 13 (20.6) 0.18
Seizures 31 (27.2) 8 (12.7) 0.03
ICH 73 (64.0) 46 (73.0) 0.22
Focal deficit 20 (17.5) 6 (9.5) 0.15
Psychiatric 3 (2.6) 0 (0.0) 0.55
Asymptomatic lacunar infarcts 17 (27.0) 7 (36.8) 0.40
Lumbar CSF characteristics
Cells (/mL) 116.3 ± 187.9 49.1 ± 59.8 0.001
Protein concentration (mg/dL) 166.6 ± 238.6 86.6 ± 114.1 0.005
Glycorrhachia (mg/dL) 42.5 ± 25.3 56.2 ± 24.6 0.001
Antibodies 88 (97.8) 41 (85.4) 0.009
Antigens 55 (85.9) 14 (50.0) < 0.0001
Degenerating stage of parasites
Vesicular only 91 (79.8) 41 (65.1) 0.04
 Single 6 (6.6) 22 (53.6) < 0.0001
Degenerating only 2 (1.7) 17 (27.0) < 0.0001
 Single 0 (0) 10 (58.8) 0.21
Vesicular + degenerating 21 (18.4) 5 (7.9) 0.08
Association with Parenchymal calcification 49 (43.0) 29 (46.0) 0.70